Skip To Main Content

Law in service of scientific innovation.

Unlocking innovation through IP strategy

Therapeutics

A split capsule releasing small spherical particles, creating a dynamic and visually appealing effect.

Medical Devices

A robotic hand.

Tissue & Cell Engineering

A translucent round petri dish, set against a plain background.

Foodtech

A husk of corn.

Diagnostics

A digital device with a screen and buttons.

Digital Health

A network of interconnected nodes, featuring varying shades of purple, illustrating relationships or connections in a geometric pattern.

Built to help breakthroughs bloom

Great ideas deserve great advocacy. As scientists-turned-attorneys, we combine scientific fluency with practical legal strategy to deliver business-focused patent protection as a catalyst for growth.

Our Approach

  • Concierge Partner Experience

    We deliver a legal experience that feels less like outside counsel and more like part of your team.

  • Technology-Strengthened Workflow

    We thoughtfully integrate technology, including AI, to minimize busywork and maximize value.

  • Predictable & Transparent Pricing

    Our billing models favor transparency and efficiency. 

  • 0

    Global Patents Issued

  • 0

    Capital Raised by Clients

  • 0

    IPOs and M&As by Clients

A portrait of Sabrina Poulos
A portrait of Sakshi Uppal
A portrait of Stephanie Dusaban Gonzales
A portrait of Victoria R. Tenge
A portrait of Kristin Havranek
A portrait of Jenniffer Huddleston
A portrait of Bonnie Choi
A portrait of Jesse Fermin

A new kind of counsel

We know what it takes to protect innovation, from discovery to commercialization. Our IP strategies are grounded in science and savvy in business.

We know what it takes to protect innovation, from discovery to commercialization. Our domain fluency drives IP strategies that are legally sound, scientifically grounded, and business‑savvy.

Meet the Team

Insights

View All

Sabrina and Bonnie have been trusted partners since our earliest days — their guidance protected our science and was a key element in our financings.

Imran Alibhai, PhD, Tvardi Therapeutics CEO